Cart
sales@molnova.com
Ranitidin
CAS No. 66357-35-5
Ranitidin( —— )
Catalog No. M18965 CAS No. 66357-35-5
Ranitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 91 | In Stock |
|
| 100MG | 120 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 362 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRanitidin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRanitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
-
DescriptionRanitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorH2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66357-35-5
-
Formula Weight314.4
-
Molecular FormulaC13H22N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN/C(=C\[N+](=O)[O-])/NCCSCc1ccc(o1)CN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fedorowicz Z. et al; Cochrane Database Syst Rev. 2012 Mar 14;(3):CD008596.
molnova catalog
related products
-
Fibrinogen Binding I...
Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411).
-
3-Phenoxybenzaldehyd...
3-phenoxybenzaldehyde cyanohydrin is an intermediate of pyrethroid insecticides such as fenpermethrin.
-
Polymyxin B
Polymyxin B, an antibiotic, combats Gram-negative infections through high-affinity binding to the bacterial wall's lipopolysaccharides (LPS), neutralizing endotoxin effects and inducing bacterial cell death by enhancing permeability.
